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INTRODUCTION
Giant cell granuloma of the respira-
tory tract or Central Giant Cell Granuloma 
(CGCG) is considered an intraosseous, non-
neoplasm tumor, responsible for less than 
7% of all the mandible expansive lesions, its 
most common site of involvement.1-3
It affects more often the young pe-
ople - 75% of the cases happen to patients 
below 30 years of age.4 There is a greater 
predilection for females.5
This paper describes a CGCG case, 
with mandible involvement and revises 
characteristics inherent to CGCG, with 
emphasis in diagnosis, thus yielding a less 
mutilating treatment.
CASE REPORT
A 30 year old brown woman came 
to our ENT outpatient ward because of a 
recurrence of a left mandible tumor, with 
a progressive, painless growth, associated 
with facial deformity after a surgical remo-
val of a giant cell reparative granuloma in 
the previous year.
She reported a prior dental removal, 
11 years before in the left mandible region. 
She denied past diseases.
The physical exam showed a hard 
and painless tumor, a bone notch in the 
left mandibular region associated with 
facial deformity.
Routine workup, serum calcium, 
phosphorus and alkaline phosphatase 
were normal.
The panoramic radiograph showed 
a radiolucent area in the left mandible 
body, a recent post-surgical area, with mild 
radiologic signs of bone regeneration.
The mandible CT scan showed a 
morphostructural alteration with bone re-
modeling and a large irregular lithic area 
in the mandible body and left mandible 
alveolar processes which could correspond 
to post-surgical alteration or tumor recur-
rence (Figure 1).
The tumor was surgically excised 
without complications.
The pathology exam confirmed 
central giant cell granuloma.
DISCUSSION
The mechanism by which these 
lesions are formed is still uncertain. Local 
causes suggested are trauma and vascular 
injuries, and the systemic causes reported 
in the literature associate the develop-
ment of CGCG with syndromes such as, 
Neurofibromatosis I, Noonan syndrome 
and hormonal disorders such as hyperpa-
rathyroidism and pregnancy.4
The clinical manifestation can 
evolve in a few weeks or take years, it is 
usually associated with tumor expansion 
and its respective compressive effects on 
adjacent structures, with a possibility for 
local discomfort; however, overt pain is 
less frequent. Clinically speaking, the diffe-
rential diagnosis of CGCG goes from a cyst 
all the way to a malignant lesion, and one 
must investigate the level of aggressiveness, 
how fast it develops, inflammatory charac-
teristics, pain and dental mobility.4
CGCG radiographic characteristics 
are not pathognomonic, they are radio-
lucent uni or multilocular images, well 
outlined and with peeled off margins.5 
One important aspect used to define lesion 
location and extension and to plan CGCG 
treatment is the ordering of a CT scan.1,4
Radiographically speaking, di-
fferential diagnoses are cysts, periapical 
granulomas, ameloblastomas, keratocysts, 
myxomas and sarcomas.
Histology shows giant cells distribu-
ted throughout the loose connective tissue4. 
Based on the histopathology exam, other 
diseases that may present characteristics 
which are undistinguishable from GCGCs, 
such as giant cell tumors, brown hyperpa-
rathyroidism tumor, aneurismal bone cyst, 
cherubism and fibrous dysplasia.4
It is important to study levels of 
calcium, phosphorus, alkaline phosphatase 
and parathormone to rule out hyperpara-
thyroidism.4
Prognostics are favorable and there 
are no reports of metastasis, which confir-
ms the benign characteristic of the lesion.4 
The aggressive types of tumor, have a 
greater rate of recurrence. The choice of 
treatment will depend on the patient’s age, 
the clinical characteristic of the lesion and 
its aggressiveness.
The treatment of choice for CGCG 
is surgical.1 Post-operative recurrence is 4 
to 12%, and it is usually associated with 
incomplete tumor resection.2
Curettage is the most used treat-
ment, because of its ease of execution and 
low grade of recurrence. Usually, the same 
recurrences respond well to a new curetta-
ge, unless the lesion is aggressive. For more 
aggressive lesions, or those that perforate 
the cortical bone and involve soft tissue, 
en-block resection may be indicated.5
Radiotherapy is contraindicated 
because of the potential for sarcomatous 
transformation that has been reported.5
For recurrent or extensive lesions, 
alternative treatments have been indicated, 
aiming at achieving lesion regression or 
termination, avoiding more invasive and 
mutilating surgical procedures.4
FINAL REMARKS
CGCGs are a reason for much rese-
arch and discussion, since there are many 
theories to explain its etiologic and clinical 
manifestations. It is a benign lesion, the-
refore proper diagnosis avoids mutilating 
radical treatments. Curattage is still used 
with high success rates. For extensive or re-
current lesions, treatment with intralesional 
injections of steroids can be useful.
REFERENCES
1. Sobrinho FPG, Martins AC, Queiroz LS et al. Gra-
nuloma reparativo de células gigantes dos seios 
etmoidal e maxilar. Rev Bras Otorrinolaringol. 
2004;70(4):555-60.
2. Arda HN, Karakus MF, Ozcan M, Arda N, Gun 
T. Giant cell reparative granuloma originating 
from the ethmoid sinus. Int J Pediatr Otorhino-
laryngol. 2003;67(1):83-7.
3. De Corso E, Politi M, Marchese MR, Pirronti T, 
Ricci R, Paludetti G. Advanced giant cell repa-
rative granuloma of the mandible: radiological 
features and surgical treatment. Acta Otorhino-
laryngol Ital. 2006;26(3):168-72.
4. Franco RL, Tavares MG, Bezerril DD et al. Gra-
nuloma de células gigantes central. Rev Bras 
Patologia Oral. 2003;2:10-6.
5. Adornato MC, Paticoff KA. Intralesional corticos-
teroid injection for treatment of central giant-
cell granuloma. Case report. JADA. 2001;132: 
186-90.
Keywords: mandible, neoplasm, tumor.
1 4th Year Medical Student - Universidade de Caxias do Sul.
2 4th Year Medical Student - Universidade de Caxias do Sul.
3 4th Year Medical Student - Universidade de Caxias do Sul.
4 4th Year Medical Student - Universidade de Caxias do Sul.
5 Full Professor of Otorhinolaryngology and head of the Ophthalmo-ENT Programs - Medical School -  Universidade de Caxias do Sul.
Universidade de Caxias do Sul.
Send correspondence to:  Rua Francisco Getúlio Vargas 1130 Petrópolis Caxias do Sul RS 95070-560.
Paper submitted to the BJORL-SGP (Publishing Management System – Brazilian Journal of Otorhinolaryngology) on May 23, 2007; 
and accepted on June 8, 2007. cod. 4539
Braz J Otorhinolaryngol.
2009;75(4):616.
Figure 1. Mandible CT scan showing morphostructural alteration 
with bone remodeling and a large irregular lithic area in the body 
and alveolar processes of the left mandible.
